Denali Therapeutics Inc (DNLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 641 | 0 | 0 | 0 | 0 |
| Gross Profit | 641 | 0 | N/A | N/A | N/A |
| Operating Expenses | 26,389 | 23,560 | 22,288 | 22,568 | 21,744 |
| Operating Income | -25,748 | -23,560 | -22,288 | -22,568 | -21,744 |
| Other Income | 2,070 | 665 | 444 | 434 | 424 |
| Pre-tax Income | -23,678 | -22,895 | -21,844 | -22,134 | -21,320 |
| Net Income Continuous | -23,678 | -22,887 | -21,844 | -22,134 | -21,320 |
| Net Income | $-23,678 | $-22,887 | $-21,844 | $-22,134 | $-21,320 |
| EPS Basic Total Ops | -0.26 | -0.74 | -2.14 | -2.29 | -2.36 |
| EPS Basic Continuous Ops | -0.26 | -0.74 | -2.14 | -2.29 | -2.36 |
| EPS Diluted Total Ops | -0.26 | -0.74 | -2.14 | -2.29 | -2.36 |
| EPS Diluted Continuous Ops | -0.26 | -0.74 | -2.14 | -2.29 | -2.36 |
| EBITDA(a) | $-25,281 | $-22,904 | $-21,296 | $-21,344 | $-20,786 |